BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3928163)

  • 1. [The effect of auranofin on lymphocyte functions in vitro].
    Strejcek J; Jíra M; Horký J
    Cas Lek Cesk; 1985 Aug; 124(33):1045-7. PubMed ID: 3928163
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of a new antirheumatic drug, triethylphosphine gold (auranofin), on in vitro lymphocyte and monocyte cytotoxicity.
    Russell AS; Davis P; Miller C
    J Rheumatol; 1982; 9(1):30-5. PubMed ID: 6806471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro boost of human NK activity by a triethylphosphine gold derivative.
    Russell AS; Nakashima S; Miller C
    Clin Exp Immunol; 1984 Jul; 57(1):207-10. PubMed ID: 6204799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auranofin effects on cytotoxicity.
    Lorber A
    J Rheumatol; 1983 Jun; 10(3):517. PubMed ID: 6411923
    [No Abstract]   [Full Text] [Related]  

  • 5. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
    Batlle Gualda E
    Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of macrophage-lymphocyte interactions by the antiarthritic gold compound, auranofin.
    Griswold DE; Lee JC; Poste G; Hanna N
    J Rheumatol; 1985 Jun; 12(3):490-7. PubMed ID: 2931519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
    Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
    Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of lymphocyte subpopulations using monoclonal antibodies in patients with rheumatoid arthritis undergoing treatment with a new gold salt (auranofin)].
    Di Matteo L; D'Incecco V; Evangelista L; Castiglione C; Consoli G
    Boll Soc Ital Biol Sper; 1985 May; 61(5):777-81. PubMed ID: 3927943
    [No Abstract]   [Full Text] [Related]  

  • 9. Auranofin.
    Davis P
    Clin Rheum Dis; 1984 Aug; 10(2):369-83. PubMed ID: 6239742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of parenteral gold after auranofin failure in rheumatoid arthritis.
    Wessel J; Davis P
    J Rheumatol; 1983 Aug; 10(4):664. PubMed ID: 6413690
    [No Abstract]   [Full Text] [Related]  

  • 11. [Distribution of gold from aurothiomalate and gold trielthylphosphine in whole blood, lymphocytes and lymphocyte chromatin of patients with chronic polyarthritis].
    Teherani DK; Altmann H; Tausch G; Eberl R
    Wien Klin Wochenschr Suppl; 1984; 156():53-5. PubMed ID: 6442060
    [No Abstract]   [Full Text] [Related]  

  • 12. [Auranofin (Ridaura). A peroral gold salt].
    Manthorpe R
    Ugeskr Laeger; 1985 Mar; 147(10):888-90. PubMed ID: 3920800
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of auranofin and sodium aurothiomalate on peripheral blood monocytes.
    Scheinberg MA; Santos LM; Finkelstein AE
    J Rheumatol; 1982; 9(3):366-9. PubMed ID: 6288942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of rheumatoid arthritis with the oral gold preparation Auranofin].
    Trnavský K; Zbojanová M
    Cas Lek Cesk; 1982 Nov; 122(45):1382-4. PubMed ID: 6821244
    [No Abstract]   [Full Text] [Related]  

  • 15. [Generation of human peripheral blood suppressor cell activity by auranofin].
    Kobayashi K; Sato H; Sekine F; Ohno I; Ohseto Y; Hamai T; Negishi M; Takahashi T
    Arerugi; 1982 Sep; 31(9):948-55. PubMed ID: 6217798
    [No Abstract]   [Full Text] [Related]  

  • 16. The augmentation of human NK-cell activity by auranofin compared to interferon.
    Russell AS; Miller C
    Int J Immunopharmacol; 1984; 6(5):451-4. PubMed ID: 6209229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in mononuclear cell function in patients with rheumatoid arthritis following treatment with auranofin.
    Coughlan RJ; Richter MB; Panayi GS
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():25-32. PubMed ID: 6432410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of in vitro and in vivo effects of gold compounds on leukocyte function: possible mechanisms of action.
    Wolach B; DeBoard JE; Coates TD; Baehner RL; Boxer LA
    J Lab Clin Med; 1982 Jul; 100(1):37-44. PubMed ID: 6283001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Therapeutic innovation in rheumatoid arthritis: worldwide auranofin symposium. Montreal, October 20-21, 1981.
    J Rheumatol Suppl; 1982; 8():1-209. PubMed ID: 6813471
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of auranofin on DNA and protein synthesis in human lymphocytes.
    Finkelstein AE; Burrone OR; Walz DT; Misher A
    J Rheumatol; 1977; 4(3):245-51. PubMed ID: 336886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.